JAMA study examines Oregon's psilocybin services model
Mental Health Weekly · 24.08.2026 · 36 (33) · 5-6
DOI: 10.1002/mhw.34984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mental Health Weekly, online erschienen am 21.08.2026. Verfasst von Valerie A. Canady.
Abstract (Originalsprache)
Given the growing interest in psychedelic‐assisted therapies, questions remain about how such services perform outside controlled clinical trials. A new JAMA Network Open study offers an early look at the risks and benefits of Oregon's state‐regulated psilocybin program, which researchers describe as the first study of its kind in the nation.
Zitieren
APA
Canady, V. A. (2026). JAMA study examines Oregon's psilocybin services model. Mental Health Weekly, 36(33), 5-6. https://doi.org/10.1002/mhw.34984
Vancouver
Canady VA. JAMA study examines Oregon's psilocybin services model. Mental Health Weekly. 2026;36(33):5-6. doi:10.1002/mhw.34984
BibTeX
@article{Canady2026,
author = {Canady, Valerie A.},
title = {JAMA study examines Oregon's psilocybin services model},
journal = {Mental Health Weekly},
year = {2026},
volume = {36},
number = {33},
pages = {5--6},
doi = {10.1002/mhw.34984}
}
EUVIMED